Ildong Pharm kicks off P2/3 clinical trial of oral Covid-19 cure in Korea
이 글자크기로 변경됩니다.
(예시) 가장 빠른 뉴스가 있고 다양한 정보, 쌍방향 소통이 숨쉬는 다음뉴스를 만나보세요. 다음뉴스는 국내외 주요이슈와 실시간 속보, 문화생활 및 다양한 분야의 뉴스를 입체적으로 전달하고 있습니다.
The Ministry of Food and Drug Safety cleared the company¡¯s IND application for a clinical study for the Covid-19 cure to evaluate its safety and pharmacological properties of the drug last week.
Under the protocol, Ildong Pharmaceutical plans to recruit more than 200 patients with asymptomatic and mild-to-moderate cases at Inha University Hospital in Korea, while Shionogi Pharmaceutical will conduct global clinical trials in Singapore and Japan among others.
Ildong Pharmaceutical aims to receive emergency use authorization for the drug in the first half of next year in Korea. Ildong Pharmaceutical expects it can sign on an agreement with its Japanese partner for technology transfer and local production of the drug for stable supply if granted marketing authorization.
S-217622 taken once daily for five days has demonstrated excellent safety and tolerability. It is known to inhibit 3CL-protease, present only in the Covid-19 virus, to prevent viral proliferation. In non-clinical studies, the treatment also showed a comparable level of viral inhibition across major Covid-19 variants, including Alpha, Beta, Gamma, and Delta.
During a recent virtual signing ceremony for the co-development agreement, Ildong CEO Yoon Woong-sub and Shionogi CEO Isao Teshirogi said that the joint development of S-217622 is not just for personal gain or business, but a social obligation of pharmaceutical companies to address the Covid-19 crisis.
Ildong Pharmaceutical shares traded 0.30 percent lower at 16,700 won ($13.99) in early afternoon on Friday.
[¨Ï Maeil Business Newspaper & mk.co.kr, All rights reserved]
Copyright © 매일경제 & mk.co.kr. 무단 전재, 재배포 및 AI학습 이용 금지
- SK Energy to test sell carbon neutral petroleum products - Pulse by Maeil Business News Korea
- Bioneer scales up production of DNA/RNA extraction kits - Pulse by Maeil Business News Korea
- Goldman Sachs testimony suggests Samsung Elec chief Lee’s active role in business deals - Pulse by Maeil Business News Korea
- KTB Investment & Securities brings Eugene Savings Bank onboard - Pulse by Maeil Business News Korea
- Korea’s long-haul LCC Air Premia to fly to America, Europe at fares 20-30% below average - Pulse by Maeil Business News Korea
- 강경준, 상간남 피소…사랑꾼 이미지 타격 [MK픽] - 스타투데이
- 덩치 대폭 키우는 HMM…藥일까 毒일까 [BUSINESS]
- 백아연, 결혼 8개월만에 엄마 된다…“임신 5개월” - MK스포츠
- 이찬원, 이태원 참사에 "노래 못해요" 했다가 봉변 당했다 - 스타투데이
- 양희은·양희경 자매, 오늘(4일) 모친상 - 스타투데이